NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for bioavailable


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on analgesics described by B. Lebourdonnec et al
2009 NOV 9 ... primates. Recently, we described a novel series of potent, selective. and orally bioavailable delta opioid receptor agonists. The lead derivative, ADL5859 (4), is currently in phase ...
Subject: Analgesics
Price: $3.00
*
Findings from Merck & Company, Inc. broaden understanding of life sciences
2009 OCT 19 ... in the Journal of Medicinal Chemistry (Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement. Journal of ...
Subject: Life Sciences
View Free
Daily News
Article
New angiogenesis research from V.C. Ardi and colleagues discussed
2009 NOV 9 ... we demonstrated that basic fibroblast growth factor(FGF-2) was a major cytokine becoming bioavailable in the onplant tissue undergoing a neutrophil proMMP-9-mediated angiogenic switch. ...
Subject: Angiogenesis
Price: $3.00
*
New life sciences research reported from V. Leclere and co-authors
2009 NOV 3 ... used for the production of diphtheria toxin (DT). A significant difference between the bioavailable iron level and the total chemical concentrations contributed by the various compounds ...
Subject: Life Sciences
Price: $3.00
*
New science and technology findings from J. Liu and co-authors described
2009 NOV 23 ... nanometer scale significantly influence the release rate of aqueous, highly toxic and bioavailable Pb in natural or industrial environments during galena dissolution."Liu and ...
Subject: Science and Technology
Price: $3.00
*
New trace element research research reported from Z. Song and co-authors
2009 OCT 27 ... that Se-enriched mycelia of S. rugoso-annulata represent a novel dietary source of bioavailable supplemental selenium." Song and colleagues published their study in ...
Subject: Trace Element Research
Price: $3.00
*
Reports from California Institute of Technology advance knowledge in science
2009 NOV 10 ... the major sink of methane in benthic ecosystems, and we now identify them as a source of bioavailable nitrogen as well. The archaea maintain their methane oxidation rates while fixing N-2 ...
Subject: Science
Price: $3.00
*
Reports outline headache and migraine study results from K.M. Connor et al
2009 NOV 2 ... 3 clinical trial, we sought to confirm the efficacy of telcagepant, the first orally bioavailable CGRP receptor antagonist." "Adults with migraine with or without aura ...
Subject: Headache and Migraine
Price: $3.00
*
Research conducted by K.R. Lamontagne and co-researchers has updated our knowledge about vascular endothelial growth factor
2009 NOV 23 ... and colleagues published their study in Angiogenesis (A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*
Research from C. Koutsari et al broadens understanding of metabolism
2009 OCT 19 ... community. Elderly women and men (>= 60 yr) with low DHEA sulfate (women and men) and bioavailable testosterone (men) concentrations and young adults. Thirty elderly women each received ...
Subject: Metabolism
Price: $3.00
*
Research from Kanazawa University in the area of hormones published
2009 NOV 16 ... Current study results from the report, 'Measurement-specific bioavailable testosterone using concanavalin A precipitation: comparison of calculated and assayed ...
Subject: Hormones
Price: $3.00
*
Research from W.S. Huang and co-researchers in the area of enzyme research published
2009 OCT 12 ... report. "Extensive SAR studies led to the discovery of potent and orally bioavailable inhibitors, some of which demonstrated in vivo efficacy. Once-daily oral administration ...
Subject: Enzyme Research
Price: $3.00
*
Researchers at China Medical University have published new data on life sciences
2009 OCT 19 ... of induced hepatic biotransformation enzymes. In summary, OSU-A9 is a potent, orally bioavailable inhibitor of the Akt-NF-kappaB signaling network, targeting multiple aspects of breast ...
Subject: Life Sciences
Price: $3.00
*
Researchers from Louisiana State University describe findings in science and technology
2009 NOV 27 ... organic pollutants in the nonlabile chemical fraction are sequestered or less bioavailable over the long-term and has implications for water quality impacts during contaminated ...
Subject: Science and Technology
Price: $3.00
*
Studies from V. Habauzit et al further understanding of bone research
2009 NOV 16 ... "The aim of the present work was to test whether H-7-glc was more bioavailable and therefore more effective than Hp in the prevention of bone loss in the OVX rat. ...
Subject: Bone Research
Price: $3.00
*
Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference
2009 NOV 16 ... - 2:30 pm poster session (Abstract #B192) XL388: A novel, selective, orally bioavailable mTORC1 and mTORC2 inhibitor that demonstrates pharmacodynamic and antitumor activity in ...
Subject: Exelixis, Inc.
Price: $3.00
*
Valensa to Market Neptune Krill Oil NKO(R) Formulations for Joint Health and Eye Health Dietary Supplements
2009 OCT 19 ... joint health. Valensa plans on using the unique biofunctional properties of the highly bioavailable Omega-3 phospholipids in NKO=AE in conjunction with several of its proprietary ...
Subject: Marketing and Licensing Agreements
Price: $3.00
*
Vitae Initiates Phase 1 Trial of Novel Renin Inhibitor
2009 OCT 5 ... VTP-27999 has a relatively simple synthetic structure and is highly bioavailable, unlike other members of the renin inhibitor class. The compound was discovered by Vitae ...
Subject: Vitae Pharmaceuticals, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login